COVID-19

The provision of OAMT presents unique challenges compared to other medications, particularly now during the current COVID-19 pandemic. Solutions to these challenges are a shared responsibility between the patient, their primary prescriber and pharmacists, and need to be made in consideration of the fine balance between the public health risk due to COVID-19 and the …

Opioid Agonist Maintenance Treatment (OAMT) Services During the COVID–19 Pandemic Read More »

The PEI College of Pharmacy has recently approved a policy for temporary closures due to COVID-19. If a pharmacy is unable to continue to operate due to COVID-19, the pharmacy may close temporarily. If a temporary closure is required, please notify the PEICP office as soon as possible via email. Please review the policy below …

Temporary Closures Read More »

Updated May 22, 2020 Pharmacy professionals in PEI are beginning to report improvements in the drug supply issues which triggered the decision to recommend 30-day supply limits in March 2020. Wholesalers have also indicated a stabilization in inventory allowing for more consistent fulfillment of pharmacy orders. Therefore, effective Friday May 22, 2020, pharmacies may begin …

Days Supply Limits Read More »

In response to the evolving health risk posed by the COVID-19 pandemic, the Office of Controlled Substances (OCS) is taking temporary measures to reduce the likelihood of spreading COVID-19 between consumers and pharmacists when returning products that may contain controlled substances to a pharmacy. More information can be found in the OCS Bulletin. Bulletin_revised If …

Post Consumer Returns During COVID Pandemic Read More »

The PEI College of Pharmacy has become aware of inappropriate prescribing of medications for the prevention and/or treatment of COVID-19 in jurisdictions in Canada and the USA. Prescriptions have included: hydroxychloroquine, azithromycin and antiretroviral medications. Inappropriate prescribing of these medications may lead to potential shortages and access for patients who require them for approved conditions. …

Prescribing of Medications to Treat COVID-19 Read More »

The Department of Health and Wellness shared the following guidance for community pharmacies: Novel Coronavirus (COVID-19) Guidance for Community Pharmacies

In response to the evolving health risk posed by the COVID-19 pandemic, the Office of Controlled Substances (OCS) is allowing temporary measures to reduce the likelihood of spreading COVID-19 between parties when taking delivery of narcotics, controlled drugs and restricted drugs while maintaining record keeping requirements. The following bulletin was shared with Licensed Dealers: OCS …

Requirements for Chain of Signatures in Light of COVID-19 Read More »